首页> 外文期刊>Neurology Research International >Pain in Amyotrophic Lateral Sclerosis: A Neglected Aspect of Disease
【24h】

Pain in Amyotrophic Lateral Sclerosis: A Neglected Aspect of Disease

机译:肌萎缩性侧索硬化症的疼痛:疾病的一个被忽视的方面

获取原文
       

摘要

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder marked by progressive loss of motor neurons, muscle wasting, and respiratory dysfunction. With disease progression, secondary symptoms arise creating new problematic conditions for ALS patients. Amongst these is pain. Although not a primary consequence of disease, pain occurs in a substantial number of individuals. Yet, studies investigating its pathomechanistic properties in the ALS patient are lacking. Therefore, more exploratory efforts into its scope, severity, impact, and treatment should be initiated. Several studies investigating the use of Clostridial neurotoxins for the reduction of pain in ALS patients suggest the potential for a neural specific approach involving focal drug delivery. Gene therapy represents a way to accomplish this. Therefore, the use of viral vectors to express transgenes that modulate the nociceptive cascade could prove to be an effective way to achieve meaningful benefit in conditions of pain in ALS.
机译:肌萎缩性侧索硬化症(ALS)是一种致命的神经退行性疾病,其特征在于运动神经元的逐渐丧失,肌肉消瘦和呼吸功能障碍。随着疾病的进展,继发症状的出现为ALS患者创造了新的问题条件。其中包括疼痛。尽管不是疾病的主要后果,但是在很多个体中都会发生疼痛。但是,尚缺乏研究其在ALS患者中的发病机制特性的研究。因此,应该对其范围,严重性,影响和治疗进行更多的探索性努力。几项研究使用梭菌神经毒素减轻ALS患者疼痛的研究表明,涉及局部药物输送的神经特异性方法的潜力。基因疗法代表了实现这一目标的一种方法。因此,使用病毒载体表达可调节伤害性级联反应的转基因可能证明是在ALS疼痛情况下获得有意义益处的有效途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号